Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-11-23

FDA Approved: ROFLUMILAST — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved the original application for a generic roflumilast from Camber Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Roflumilast (roflumilast)

Snippet

ORIG AP for ROFLUMILAST (ROFLUMILAST)